FACULTY
Kathleen H. Besinque, PharmD, MSEd
Associate Professor of Clinical Pharmacy
School of Pharmacy
University of Southern California
Los Angeles, CA

FINANCIAL DISCLOSURE
Kathleen H. Besinque, PharmD, MSEd has no real or apparent conflicts of interest in relation to this program.

ACCREDITATION STATEMENT
Pharmacy
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-09-027-H01-P; 0430-0000-09-027-H01-T
Credits: 2.0 hours (0.20 ceu)

TYPE OF ACTIVITY: Knowledge

Media: Internet

Estimated time to complete activity:
Estimated time to complete this activity is 120 minutes.

Exam processing inquiries and other inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696

PROCEDURE
Please complete the posttest questions and activity evaluation online at: www.powerpak.com (a username and password are required to access your account). Upon passing the exam with a score of 70% or better, you can print out your statement of credit immediately. You can also view your test history at any time and print out duplicate statements from the Web site.

TARGET AUDIENCE
This accredited activity is targeted to pharmacists and pharmacy technicians.

GOAL
The goals of this educational program are to update pharmacists and other healthcare professionals on the current clinical and regulatory information related to levonorgestrel- based emergency contraception and to provide effective strategies for educating consumers about emergency contraception.

EDUCATIONAL OBJECTIVES

1. Discuss the clinical indications for emergency contraception;*
2. Compare available levonorgestrel-only emergency contraceptive regimens and the requirements associated with the nonprescription sale of these products;*
3. Describe the evidence for the mechanism of action and safety profile of levonorgestrel- only emergency contraceptive regimens;*
4. Discuss opportunities for pharmacists to provide improved access to emergency contraception, including identification of and reduction of barriers in the pharmacy environment;* and
5. Describe strategies to improve education and counseling of consumers regarding the effective use of levonorgestrel emergency contraception regimens.*

Disclosure of Unlabeled Use
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC and Teva Women’s Health. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer’s package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.